Cargando…
A chromosome 4 trisomy contributes to increased fluconazole resistance in a clinical isolate of Candida albicans
Candida albicans is an important opportunistic fungal pathogen capable of causing both mucosal and disseminated disease. Infections are often treated with fluconazole, a front-line antifungal drug that targets the biosynthesis of ergosterol, a major component of the fungal cell membrane. Resistance...
Autores principales: | Anderson, Matthew Z., Saha, Amrita, Haseeb, Abid, Bennett, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737213/ https://www.ncbi.nlm.nih.gov/pubmed/28640746 http://dx.doi.org/10.1099/mic.0.000478 |
Ejemplares similares
-
Chromosome 1 trisomy confers resistance to aureobasidin A in Candida albicans
por: Zheng, Lijun, et al.
Publicado: (2023) -
Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017) -
Biofilm Alterations on the Stepwise Acquisition of Fluconazole-resistant Candida Albicans Isolates
por: Song, Na-Na, et al.
Publicado: (2022) -
Fluconazole impacts the extracellular matrix of fluconazole-susceptible and -resistant Candida albicans and Candida glabrata biofilms
por: Panariello, Beatriz Helena Dias, et al.
Publicado: (2018) -
The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant Candida albicans
por: Li, Liping, et al.
Publicado: (2019)